Home » , , , , , , » Diabetic Insulin Product Availability and Market Challenges Study in India

Diabetic Insulin Product Availability and Market Challenges Study in India



Objectives:
To determine the extent to which the availability of DegludecPlus will impact LANTUS

Methodology:
60 minute viewed IDIs.

Screening criteria:          
  • In practice as either PCP or specialist for between 3 and 30 years
  • Mix of settings
  • Spending at least 70% of professional time in direct patient care
  • PCPs see at least 30 diabetic patients a month
  • Endos/Diabs see at least 40 diabetic patients a month
  • Initiate Lantus, Levemir and Pre-mix insulin
  • At least 4 patients on Lantus, Levemir AND 20 on Humalog Mix and/or Novolog Mix

0 comments:

Post a Comment